Testicular, Penile, and Rare Malignancies
Testicular, Penile, and Rare Malignancies
Leah LawrenceTesticular, Penile, and Rare Malignancies | October 31, 2022
Progression-free survival for stage IIA and stage IIB seminoma was improved with single-dose carboplatin and radiotherapy.
Read More
Leah LawrenceTesticular, Penile, and Rare Malignancies | October 4, 2022
Hispanic males had the highest incidence of HPV-associated penile cancers and were diagnosed at later stages.
Leah LawrenceESMO 2022 | September 16, 2022
Neoadjuvant platinum-based chemotherapy has been found effective for treating metastatic penile squamous cell carcinoma.
Leah LawrenceESMO 2022 | September 16, 2022
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
Leah LawrenceTesticular, Penile, and Rare Malignancies | August 2, 2022
Many TGCT survivors are referred for life-long monitoring due to an increased risk for skin cancer and melanoma.
GU Oncology Now EditorsUrothelial Carcinoma | June 3, 2022
In this paper, we present age-standardized cancer incidence and mortality rates in the Faroe Islands.
GU Oncology Now EditorsRenal Cell Carcinoma | June 3, 2022
RLRN has been widely used in the surgical treatment of renal cancer due to small wound, less bleeding, and rapid recovery.
GU Oncology Now EditorsTesticular, Penile, and Rare Malignancies | June 2, 2022
Arterioureteral fistulas (AUF) following ileal conduit reconstruction are rare and not well-studied.
GU Oncology Now EditorsRenal Cell Carcinoma | June 1, 2022
Researchers determined the underlying oncogenic functions of hepcidin in common male genitourinary system tumors.
GU Oncology Now EditorsUrothelial Carcinoma | May 31, 2022
Hematospermia, although often found to be a benign condition, can be an alarming sign.
GU Oncology Now EditorsTesticular, Penile, and Rare Malignancies | May 31, 2022
Synovial Sarcoma (SS) is a rare soft-tissue malignancy. Only about 15% of SS originates from the retroperitoneum.
GU Oncology Now EditorsTesticular, Penile, and Rare Malignancies | May 27, 2022
Cisplatin is a widely used chemotherapeutic agent, but its utility is limited because of cisplatin-induced ototoxicity.
GU Oncology Now EditorsTesticular, Penile, and Rare Malignancies | May 27, 2022
Cancer of unknown primary (CUP) is an aggressive rare malignancy with limited treatment options.
GU Oncology Now EditorsTesticular, Penile, and Rare Malignancies | May 26, 2022
Malignant rhabdoid tumor is a rare, aggressive pediatric malignancy most commonly diagnosed in those below the age of three.
The UromigosThe Uromigos | December 9, 2020
Christian Kollmannsberger gets into the Christmas spirit by discussing highlights of 2020 in the world of testis cancer.
The UromigosThe Uromigos | July 18, 2020
Dr. Jan Oldenburg discusses stage 1 testis cancer treatment choices, the dilemma of high-dose therapy for relapse, and more.
Advertisement
Advertisement